Trial · NCT04098835
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Participant satisfaction with ASCEND, as measured by the Client Satisfaction Questionnaire-8 (CSQ-8) | 5 weeks (at the conclusion of treatment) | The CSQ-8 is a self-report measure of participant satisfaction with the intervention. Scores range from 8-32 with higher scores indicating greater satisfaction. |
| Primary | Participant impression of ASCEND as a credible treatment to improve cognition, as measured by the Credibility and Expectancy Questionnaire (CEQ). | 5 weeks (at the conclusion of treatment) | The CEQ is a self-report measure that assesses participants' perceived benefit and improvement from the intervention. Each item is scored on a 1-9 Likert-type scale or as a percentage rating from 0% to 100% in 10% increments. |
| Secondary | Change in auditory attention and working memory, as measured by the Digit Span test | Baseline, 5 weeks | Performance-based measure of attention/working memory with scores ranging from 0-48, with higher scores indicating better performance. |
| Secondary | Change in visual attention and working memory, as measured by the Symbol Span test | Baseline, 5 weeks | Performance-based measure of attention/working memory with scores ranging from 0-50, with higher scores indicating better performance. |
| Secondary | Change in divided attention and working memory, as measured by the Symbol-Digit Modalities Test | Baseline, 5 weeks | Performance-based measure of divided attention/working memory with scores ranging from 0-120, with higher scores indicating better performance. |
| Secondary | Change in divided attention and processing speed, as measured by the Trail Making Test | Baseline, 5 weeks | Performance-based and timed measure of divided attention/processing speed with lower scores indicating better performance (faster completion time). |
| Secondary | Change in selective attention and inhibitory control, as measured by the Stroop Test | Baseline, 5 weeks | Performance-based and timed measure of selective attention and inhibition, with higher scores indicating better performance. |
| Secondary | Change in rapid working memory and mental arithmetic, as measured by the Paced Auditory Serial Addition Test (PASAT) | Baseline, 5 weeks | Performance-based and timed measure of rapid working memory, with higher scores indicating better performance. |
| Secondary | Change in attention and working memory as measured by the Mental Control test | Baseline, 5 weeks | Performance-based measure of simple auditory attention and working memory. Scores range from 0-12 with higher scores indicating better performance. |
| Secondary | Change in executive functioning as measured by the Weekly Calendar Planning Activity | Baseline, 5 weeks | Performance-based measure of executive functioning. Higher scores indicate better performance. |
| Secondary | Change in self-reported executive functioning as measured by the Behavior Rating Inventory of Executive Function-Adult | Baseline, 5 weeks | Self-report measure of executive functioning. Higher scores indicate greater problems with executive dysfunction in daily life. |
| Secondary | Change in self-reported cognitive symptoms due to stroke, as measured by the Patient Reported Evaluation of Cognitive State (PRECIS). | Baseline, 5 weeks | Self-report measure of cognitive difficulties after stroke. Scores range from 0-128 with higher scores indicating greater cognitive problems in daily life due to stroke. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04098835/registered